RoActemra/Actemra (tocilizumab)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for RoActemra/Actemra (tocilizumab), covering 2016-08-29 to 2016-11-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study of The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDs [Phase 4]